Orion Portfolio Solutions LLC raised its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 22.0% in the third quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 12,855 shares of the medical equipment provider's stock after purchasing an additional 2,315 shares during the period. Orion Portfolio Solutions LLC's holdings in Intuitive Surgical were worth $6,315,000 at the end of the most recent reporting period.
Several other institutional investors have also recently made changes to their positions in ISRG. Ridgewood Investments LLC bought a new position in shares of Intuitive Surgical in the 2nd quarter worth approximately $26,000. Godsey & Gibb Inc. raised its position in shares of Intuitive Surgical by 140.0% in the 3rd quarter. Godsey & Gibb Inc. now owns 60 shares of the medical equipment provider's stock worth $29,000 after acquiring an additional 35 shares in the last quarter. LGT Financial Advisors LLC raised its position in shares of Intuitive Surgical by 415.4% in the 2nd quarter. LGT Financial Advisors LLC now owns 67 shares of the medical equipment provider's stock worth $30,000 after acquiring an additional 54 shares in the last quarter. MidAtlantic Capital Management Inc. bought a new position in shares of Intuitive Surgical in the 3rd quarter worth approximately $33,000. Finally, Mark Sheptoff Financial Planning LLC bought a new position in shares of Intuitive Surgical in the 2nd quarter worth approximately $37,000. Institutional investors own 83.64% of the company's stock.
Insider Transactions at Intuitive Surgical
In related news, EVP Robert Desantis sold 376 shares of the firm's stock in a transaction on Friday, November 29th. The stock was sold at an average price of $539.00, for a total value of $202,664.00. Following the transaction, the executive vice president now directly owns 5,506 shares of the company's stock, valued at approximately $2,967,734. This trade represents a 6.39 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. Also, insider Mark Brosius sold 2,115 shares of the firm's stock in a transaction on Thursday, September 12th. The stock was sold at an average price of $491.91, for a total value of $1,040,389.65. Following the completion of the transaction, the insider now directly owns 295 shares in the company, valued at approximately $145,113.45. This represents a 87.76 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 50,723 shares of company stock worth $26,241,747 in the last ninety days. Insiders own 0.90% of the company's stock.
Analyst Upgrades and Downgrades
Several brokerages have recently issued reports on ISRG. Truist Financial increased their target price on Intuitive Surgical from $520.00 to $570.00 and gave the stock a "buy" rating in a research report on Monday, October 14th. Morgan Stanley upgraded Intuitive Surgical from an "equal weight" rating to an "overweight" rating and upped their price target for the stock from $522.00 to $650.00 in a research note on Monday, December 2nd. Leerink Partners upped their price target on Intuitive Surgical from $489.00 to $502.00 in a research note on Thursday, October 17th. Mizuho upped their price target on Intuitive Surgical from $440.00 to $500.00 in a research note on Thursday, October 17th. Finally, BTIG Research upped their price target on Intuitive Surgical from $535.00 to $561.00 and gave the stock a "buy" rating in a research note on Tuesday, November 26th. One analyst has rated the stock with a sell rating, four have given a hold rating and fifteen have issued a buy rating to the stock. According to data from MarketBeat.com, the company has an average rating of "Moderate Buy" and an average target price of $541.33.
Check Out Our Latest Report on ISRG
Intuitive Surgical Stock Performance
Shares of ISRG stock traded down $11.55 on Monday, reaching $538.86. The stock had a trading volume of 1,428,757 shares, compared to its average volume of 1,445,554. The stock has a market cap of $191.93 billion, a P/E ratio of 86.63, a price-to-earnings-growth ratio of 5.41 and a beta of 1.38. Intuitive Surgical, Inc. has a 1 year low of $309.80 and a 1 year high of $556.23. The company has a 50 day simple moving average of $517.16 and a 200 day simple moving average of $475.65.
Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings results on Thursday, October 17th. The medical equipment provider reported $1.56 earnings per share (EPS) for the quarter, topping analysts' consensus estimates of $1.24 by $0.32. The firm had revenue of $2.04 billion for the quarter, compared to the consensus estimate of $2.01 billion. Intuitive Surgical had a return on equity of 13.41% and a net margin of 28.51%. On average, equities research analysts anticipate that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.
Intuitive Surgical Company Profile
(
Free Report)
Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.
Recommended Stories
Before you consider Intuitive Surgical, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Intuitive Surgical wasn't on the list.
While Intuitive Surgical currently has a "Moderate Buy" rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Need to stretch out your 401K or Roth IRA plan? Use these time-tested investing strategies to grow the monthly retirement income that your stock portfolio generates.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.